Bausch Health Companies (BHC) Net Cash Flow (2009 - 2026)
Bausch Health Companies (BHC) posted Net Cash Flow of $528.0 million for Q2 2026, up 5966.67% sequentially from -$9.0 million in Q1 2026, and down 3.47% YoY from $547.0 million in Q2 2025.
Bausch Health Companies (BHC) Net Cash Flow (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Net Cash Flow for 18 years, with the latest figure at $528.0 million in Q2 2026.
- Quarterly Net Cash Flow fell 3.47% year-over-year to $528.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $100.0 million (down 90.76% YoY) and the FY2025 annual result came in at $63.0 million, down 77.09% from the prior year.
- Net Cash Flow climbed to $528.0 million in Q2 2026 per BHC's latest filing, from -$9.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $547.0 million in Q2 2025 and troughed at -$1.4 billion in Q3 2022.
- A 5-year average of -$15.9 million and a median of $23.5 million in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow tumbled 26940.0% in 2022, then soared 544.72% in 2025.
- Over 5 years, Net Cash Flow stood at $63.0 million in 2022, then jumped by 158.73% to $163.0 million in 2023, then jumped by 198.16% to $486.0 million in 2024, then sank by 104.53% to -$22.0 million in 2025, then jumped by 2500.0% to $528.0 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $528.0 million, -$9.0 million, and -$22.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 732.63 Mn | 2.10 Bn | 528.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 528.00 Mn |
| Jun 30, 2026 | 528.00 Mn |
| Mar 31, 2026 | -9.00 Mn |
| Mar 31, 2026 | -9.00 Mn |
| Dec 31, 2025 | -22.00 Mn |
| Dec 31, 2025 | -22.00 Mn |
| Sep 30, 2025 | -397.00 Mn |
| Sep 30, 2025 | -397.00 Mn |
| Jun 30, 2025 | 547.00 Mn |
| Jun 30, 2025 | 547.00 Mn |
| Mar 31, 2025 | -65.00 Mn |
| Mar 31, 2025 | -65.00 Mn |
| Dec 31, 2024 | 486.00 Mn |
| Dec 31, 2024 | 486.00 Mn |
| Sep 30, 2024 | 114.00 Mn |
| Sep 30, 2024 | 114.00 Mn |
| Jun 30, 2024 | -123.00 Mn |
| Jun 30, 2024 | -123.00 Mn |
| Mar 31, 2024 | -202.00 Mn |
| Mar 31, 2024 | -202.00 Mn |